ArticleOncology and therapy2020
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.
Article in Oncology and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology.Exploration of targeted anti-tumor therapy · 2023Pooled it
- Evaluating the impact of COVID-19 on cancer care: a comprehensive analysis of treatment modifications, risk factors, and patient outcomes.BMC infectious diseases · 2025Article
- RapidExtracellular vesicles and circulating nucleic acids · 2025Article
- Article
- Differences in Emotional Distress Among Black and White Breast Cancer Survivors During the Covid-19 Pandemic: a National Survey.Journal of racial and ethnic health disparities · 2022Article
- Article
- Emerging issues related to COVID-19 vaccination in patients with cancer.Oncology and therapy · 2021Article
- Cancer Australia consensus statement on COVID-19 and cancer care: embedding high value changes in practice.The Medical journal of Australia · 2021Article
- Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea.Critical reviews in oncology/hematology · 2021Review
- Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021Article
- Fiberoptic bronchoscopy via intubation box during COVID-19 pandemic.Journal of surgical oncology · 2021Article
- Sexist Myths Emergency Healthcare Professionals and Factors Associated with the Detection of Intimate Partner Violence in Women.International journal of environmental research and public health · 2021Article
- Cancer Research in the Time of COVID-19: A Colombian Narrative.Frontiers in public health · 2021Article
- Quality of Life of People with Cancer in the Era of the COVID-19 Pandemic in India: A Systematic Review.Clinical practice and epidemiology in mental health : CP & EMH · 2021Review
- An Overview of the International Literature on Health-Related Quality of Life, Mental Health and Psychosocial Issues in People with Cancer.Clinical practice and epidemiology in mental health : CP & EMH · 2021Article
- Managing children with brain tumors during the COVID-19 era: Don't stop the care!Computational and structural biotechnology journal · 2021Review
- The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.Current breast cancer reports · 2021Review
- Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward.Cancer treatment and research communications · 2021Review
- Influence of the First Wave of the COVID-19 Pandemic on Cancer Care in a German Comprehensive Cancer Center.Frontiers in public health · 2021Article
- Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United States.Advances in radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 13 institutions in 9 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer than seen in the general population. Also, patients with malignancy are likely to be more vulnerable than the general population to contracting COVID-19. Mortality is significantly higher in patients with both cancer and COVID-19 compared with the overall COVID-19-positive population. The early months of the pandemic saw a decrease in cancer screening and diagnosis, as well as postponement of standard treatments, which could lead to excess deaths from cancer in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.